A Donepezil hydrochloride, Aricept CEP of the European Pharmacopoeia monograph is often referred to as a Donepezil hydrochloride, Aricept Certificate of Suitability (COS). The purpose of a Donepezil hydrochloride, Aricept CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Donepezil hydrochloride, Aricept EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Donepezil hydrochloride, Aricept to their clients by showing that a Donepezil hydrochloride, Aricept CEP has been issued for it. The manufacturer submits a Donepezil hydrochloride, Aricept CEP (COS) as part of the market authorization procedure, and it takes on the role of a Donepezil hydrochloride, Aricept CEP holder for the record. Additionally, the data presented in the Donepezil hydrochloride, Aricept CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Donepezil hydrochloride, Aricept DMF.
A Donepezil hydrochloride, Aricept CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Donepezil hydrochloride, Aricept CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Donepezil hydrochloride, Aricept suppliers with CEP (COS) on PharmaCompass.